Pancreatic cancer triggers diabetes through TGF-β–mediated selective depletion of islet β-cells

Abstract excerpt

Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease that remains incurable because of late diagnosis, which renders any therapeutic intervention challenging. Most PDAC patients develop de novo diabetes, which exacerbates their morbidity and mortality. How PDAC triggers diabetes is still unfolding. Using a mouse model of KrasG12D-driven PDAC, which faithfully recapitulates the progression of the human...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Metabolism, Diabetes, and Cancer
• Share to Pancreatic and Hepatic Oncology Research
• Share to Pancreatic function and diabetes